Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: Application of the human classification

Virchows Archiv

Volumn 453, Issue 2, 2008, Pages 123-132

  Gama, A ^a   Alves, A ^a   Schmitt, F ^b,c  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Canine; Classification; Immunohistochemistry; Mammary carcinoma

Indexed keywords

CADHERIN; CADHERIN P; CYTOKERATIN 5; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROTEIN P63;

ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOG; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; CADHERINS; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; KERATIN-5; MAMMARY NEOPLASMS, ANIMAL; PHENOTYPE; PHOSPHOPROTEINS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; TRANS-ACTIVATORS;

EID: 49349088861     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-008-0644-3     Document Type: Article

References (54)

1. DM Abd El-Rehim SE Pinder CE Paish J Bell RW Blamey JF Robertson RI Nicholson IO Ellis 2004 Expression of luminal and basal cytokeratins in human breast carcinoma J Pathol 203 661 671
2. TE Ahern RC Bird AE Church Bird LG Wolfe 1996 Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines Am J Vet Res 57 693 696
3. S Banerjee JS Reis-Filho S Ashley D Steele A Ashworth SR Lakhani IE Smith 2006 Basal-like breast carcinomas: clinical outcome and response to chemotherapy J Clin Pathol 59 729 735
4. MW Beckmann D Niederacher HG Schnürch BA Gusterson HG Bender 1997 Multistep carcinogenesis of breast cancer and tumour heterogeneity J Mol Med 75 429 439
5. D Birnbaum F Bertucci C Ginestier R Tagett J Jacquemier E Charafe-Jauffret 2004 Basal and luminal breast cancers: basic or luminous? Int J Oncol 25 249 258
6. W Boecker H Buerger 2003 Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept Cell Prolif 36 Suppl 1 73 84
7. W Boecker R Moll C Poremba R Holland PJ Van Diest P Dervan H Burger D Wai R Ina Diallo B Brandt H Herbst A Schmidt MM Lerch IB Buchwallow 2002 Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept Lab Invest 82 737 746
8. JE Dick 2003 Breast cancer stem cells revealed Proc Natl Acad Sci U S A 100 3547 3549
9. J DiRenzo S Signoretti N Nakamura R Rivera-Gonzalez W Sellers M Loda M Brown 2002 Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line Cancer Res 62 89 98
10. AP Dutra NVM Granja FC Schmitt GD Cassali 2004 c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors Braz J Med Biol Res 37 1673 1681
11. Elston CW, Ellis IO (1998) Assessment of histological grade. In: Elston CW, Ellis IO (eds) Systemic pathology. The breast. 3rd edn. Churchill Livingstone, London, pp 365-384
12. LG Fulford JS Reis-Filho K Ryder C Jones CE Gillett A Hanby D Easton SR Lakhani 2007 Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival Breast Cancer Res 9 R4
13. A Gama J Paredes A Albergaria F Gartner FC Schmitt 2004 P-cadherin expression in canine mammary tissues J Comp Pathol 130 13 20
14. Gama A, Paredes J, Gartner F, Alves A, Schmitt FC (2008) Expression of E-cadherin, P-cadherin and b-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Vet J. 177:45-53 doi: 10.1016/j.tvjl.2007.05.024
15. M Geraldes F Gärtner F Schmitt 2000 Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours Vet Rec 146 403 406
16. SM Griffey BR Madewell SH Dairkee JE Hunt DK Naydan RJ Higgins 1993 Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands Vet Pathol 30 155 161
17. Hsu W-L, Huang H-M, Liao J-W, Wong M-L, Chang S-C (2007) Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene. Vet J. doi: 10.1016/j.tvjl.2007.10.013
18. M Jumppanen S Gruvberger-Saal P Kauraniemi M Tanner PO Bendahl M Lundin M Krogh P Kataja A Borg M Fernö J Isola 2007 Basal-like phenotype is not associated with patient survival in estrogen receptor negative breast cancers Breast Cancer Res 9 R16
19. M Karayannopoulou E Kaldrymidou TC Constantinidis A Dessiris 2005 Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method J Comp Pathol 133 246 252
20. MJ Kim JY Ro SH Ahn HH Kim SB Kim G Gong 2006 Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes Human Pathol 37 1217 1226
21. CH Lee WH Kim JH Lim MS Kang DY Kim OK Kweon 2004 Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors J Vet Sci 5 63 69
22. CA Livasy G Karaca R Nanda MS Tretiakova OI Olopade DT Moore CM Perou 2006 Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Mod Path 19 264 271
23. J Martin de las Mulas Y Millán R Dios 2005 A prospective analysis of immunohistochemically determined estrogen receptor a and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog Vet Pathol 42 200 212
24. J Martin de las Mulas J Ordás Y Millán V Fernández-Soria S Ramón y Cajal 2003 Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study Breast Cancer Res Treat 80 363 367
25. AJ Matos CC Lopes AM Faustino JG Carvalheira MS dos Santos GR Rutteman F Gartner 2006 MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study Anticancer Res 26 1821 1826
26. AJ Matos CC Lopes AM Faustino JG Carvalheira GR Rutteman MF Gärtner 2007 E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours APMIS 115 327 334
27. I Matos R Dufloth M Alvarenga LC Zeferino F Schmitt 2005 p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas Virchows Arch 447 688 694
28. F Millanta M Calandrella G Bari M Niccolini I Vannozzi A Poli 2005 Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues Res Vet Sci 79 225 232
29. Misdorp W (2002) Tumours of the mammary gland. In: Meuten DJ (ed) Tumors in domestic animals. 4th edn. Iowa State Press, Iowa, pp 575-606
30. Misdorp W, Else RW, Hellmén E, Lipscomb TP (1999) Histological classification of mammary tumors of the dog and the cat, Vol VII, 2nd series. Armed Forces Institute of Pathology, American Registry of Pathology, Washington D.C., and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, pp 1-59
31. W Misdorp AA Hart 1976 Prognostic factors in canine mammary cancer J Natl Cancer Inst 56 779 786
32. VR Nerurkar AR Chitale BV Jalnakurpar SN Naik VS Lalitha 1989 Comparative pathology of canine mammary tumours J Comp Pathol 101 389 397
33. TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu T Hernandez-Boussard C Livasy D Cowan L Dressler LA Akslen J Ragaz AM Gown CB Gilks M van de Rijn CM Perou 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374
34. A Nieto L Peña MD Perez-Alenza MA Sanchez JM Flores M Castaño 2000 Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance Vet Pathol 37 239 247
35. A Peralta Soler KA Knudsen H Salazar AC Han AA Keshgegian 1999 P-cadherin expression in breast carcinoma indicates poor survival Cancer 86 1263 1272
36. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 747 752
37. EA Rakha DA El-Rehim C Paish AR Green AH Lee JF Robertson RW Blamey D Macmillan IO Ellis 2006 Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance Eur J Cancer 42 3149 3156
38. EA Rakha ME El-Sayed AR Green EC Paish AH Lee IO Ellis 2007 Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression Histopathology 50 434 438
39. Rakha EA, El-Sayed ME, Reis-Filho J, Ellis IO (2008) Patho-biological aspects of basal-like breast cancer. Breast Cancer Res Treat. doi: 10.1007/s10549-008-9952-1
40. EA Rakha TC Putti DM Abd El-Rehim C Paish AR Green DG Powe AH Lee JF Robertson IO Ellis 2006 Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation J Pathol 208 495 506
41. F Revillion J Bonnetarre JP Peyrat 1998 ErbB-2 oncogene in human breast cancer and its clinical significance Eur J Cancer 34 791 808
42. A Rungsipipat S Tateyama R Yamaguchi K Uchida N Miyoshi T Hayashi 1999 Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors J Vet Med Sci 61 27 32
43. Rutteman GR, Withrow SJ, MacEwen EG (2001) Tumors of the mammary gland. In: Withrow SJ, MacEwen BR (eds) Small animal clinical oncology. Saunders, Philadelphia, pp 455-477
44. Sarli G, Sassi F, Brunetti B, Benazzi C (2007) Luminal-like A and B types in canine mammary carcinomas. 25th Annual Meeting ESVP, Munich (Germany), pp. 187
45. EA Sartin S Barnes RP Kwapien LG Wolfe 1992 Estrogen and progesterone receptor status of mammary carcinomas and correlation with clinical outcome in dogs Am J Vet Res 53 2196 2200
46. DJ Slamon GM Clark SG Wong WJ Levin A Ullrich WL McGuire 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 177 182
47. T Sorlie CM Perou R Tibshirani T Aas S Geisler H Johnsen T Hastie MB Eisen MV Rijn SS Jeffrey T Thorsen H Quist JC Matese PO Brown D Botstein PE Lonning AL Borresen-Dale 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 10869 10874
48. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel S Deng H Johnsen R Pesich S Geisler J Demeter CM Perou PE Lonning PO Brown AL Borresen-Dale D Botstein 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 100 8418 8423
49. C Sotiriou SY Neo LM McShane EL Korn PM Long A Jazaeri P Martiat SB Fox AL Harris ET Liu 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci U S A 100 10393 10398
50. DS Tan C Marchió RL Jones K Savage IE Smith M Dowsett JS Reis-Filho 2008 Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients Breast Cancer Res Treat 111 27 44
51. P Tang J Wang P Bourne 2008 Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same? Human Pathol 39 506 513
52. M van de Rijn CM Perou R Tibshirani P Haas O Kallioniemi J Kononen J Torhorst G Sauter M Zuber OR Kochli F Mross H Dieterich R Seitz D Ross D Botstein P Brown 2002 Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome Am J Pathol 161 1991 1996
53. LJ van't Veer H Dai MJ van de Vijver YD He AA Hart M Mao HL Peterse K van der Kooy MJ Marton AT Witteveen GJ Schreiber RM Kerkhoven C Roberts PS Linsley R Bernards SH Friend 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530 536
54. ML Zaidan Dagli 2008 The search for suitable prognostic markers for canine mammary tumors: a promising ontlook Vet J 177 3 5